Latest News and Press Releases
Want to stay updated on the latest news?
-
Abivax Announces Launch of Public Offering of American Depositary Shares PARIS, France – June 30, 2026 – 10:45 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or...
-
Abivax annonce le lancement d’une offre au public d’American Depositary Shares PARIS, France – 30 juin 2026 – 22h45 CEST – Abivax SA (Euronext Paris : FR0012333284 – ABVX) (« Abivax » ou la « Société...
-
Rocket Lab has entered into a definitive agreement to acquire Iridium, a leader in global voice, data, and PNT satellite services.
-
Acquisition adds navtemadlin, a late-stage rare blood cancer asset in Phase III. This hemato-oncology program in myelofibrosis expands Ipsen’s growing Oncology portfolioNavtemadlin, an oral MDM2...
-
Cette acquisition ajoute le navtemadlin, un candidat médicament de stade avancé contre un cancer rare du sang, actuellement en phase III de développement clinique. Ce programme d'hémato-oncologie,...
-
All amounts in U.S. dollars unless otherwise stated TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Onex Partners (“Onex”) today announced that the Onex Partners Opportunities Fund, TriWest Capital...
-
DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus...
-
SEATTLE, June 24, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today that Margi Tooth, Chief Executive Officer and President,...
-
DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus...
-
FAIR LAWN, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Columbia Financial, Inc. (“Columbia”) (NASDAQ: CLBK), a Delaware corporation and the mid-tier holding company for Columbia Bank, announced today,...